Yahoo Finance

Antineoplastic Agents (Anticancer Drugs) Research Report 2024: Global Market to Surpass $225 Billion by 2030 - Growing Focus on Rare Cancers and Orphan Drug Development ...

Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "Antineoplastic Agents - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
ascopubs.org

Podcast: Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards

Dr. Bradley Hunter, MD, MPH and Ms. Amy Evers, BSN, RN, OCN, MBA join us on the latest episode of the ASCO Guidelines Podcast to share key points and insights on the updated ASCO-ONS antineoplastic ...
ascopubs.org

Exploration of the ASCO and ESMO Value Frameworks for Antineoplastic Drugs

Financial Impact of Cancer Drug Wastage and Potential Cost Savings From Mitigation Strategies Our analysis of the ASCO and ESMO value frameworks illuminates the heterogeneous benefit of new ...
Reuters

OXiGENE: Triple-drug combination therapy shows promising antineoplastic activity

Co announces the publication of data from a preclinical study of two triple-drug combinations -- combretastatin A4 phosphate / CA4P, paclitaxel, and manumycin A, and CA4P, paclitaxel, and carboplatin.